FREE Account Opening + No Clearing Fees
Loading...

Zydus Lifesciences Buyback Latest News Today

Zydus Lifesciences Buyback Detail
Buyback Record Date June 2, 2022
Buyback Open Date June 23, 2022
Buyback Closing Date July 6, 2022
Issue Size (Shares) 1.15 Crores
Issue Size (Amount) ₹750.00 Crores
Buyback Price ₹650 per Share
  1. Zydus Lifesciences Rs 750 cr-share buyback to open on June 23

    June 14, 2022 5:01:00 PM

    The drug firm, earlier known as Cadila Healthcare, has fixed July 15, 2022 as the last date for the settlement of bids on stock exchanges which may even happen early, as per a regulatory filing. The ...

    Published by : Zee Business
  2. USFDA Flags Zydus Lifesciences Gujarat Facility for Regulatory Issues

    July 18, 2024 4:16:00 PM

    Zydus Lifesciences' injectables manufacturing facility in Jarod, near Vadodara, has been classified as 'Official Action Indicated' by the USFDA following an inspection. This implies regulatory ...

    Published by : devdiscourse
  3. As Roche blocks Zydus� Pertuzumab launch, experts see murky corporate rivalry

    July 19, 2024 2:21:00 AM

    An interim injunction from the Delhi High Court paused Zydus Lifesciences� bid to launch the biosimilars of Roche�s breast cancer drug Perjeta (pertuzumab). But as the story unfolds ...

    Published by : health.economictimes.indiatimes
  4. Zydus Ties With Takeda To Sell GERD Drug

    July 17, 2024 1:58:00 PM

    (MENAFN- Live Mint) New Delhi: Ahmedabad based Zydus Lifesciences Limited has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company to market the novel ...

    Published by : Mena FN
  5. 226% return in 2 years: Zydus Lifesciences shares in focus as company inks licensing pact with Takeda

    July 18, 2024 7:24:00 PM

    Zydus Lifesciences Share Price NSE, BSE: Zydus Lifesciences has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company to market the novel Potassium Competitive ...

    Published by : Zee Business
  6. Zydus Lifesciences gets USFDA nod to market generic drug

    April 10, 2023 3:49:00 AM

    Photo: Mint Zydus Lifesciences on Tuesday said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma. The company has received the ...

    Published by : Mint
  7. Zydus Lifesciences Partners with Takeda to Launch Novel GERD Drug in India

    July 17, 2024 4:01:00 PM

    Zydus Lifesciences announced a licensing agreement with Takeda Pharmaceutical to market Vonoprazan, a drug for gastroesophageal reflux disease (GERD), in India. Marketed under the brand name Vault, ...

    Published by : devdiscourse
  8. Zydus Lifesciences

    June 14, 2024 11:40:00 PM

    The tentative approval by the US Food and Drug Administration (USFDA) is for Azilsartan Medoxomil and Chlorthalidone tablets of strengths 40 mg/12.5 mg and 40 mg/25 mg, Zydus Lifesciences said in ...

    Published by : moneycontrol.com
  9. Zydus Lifesciences posts 26.8% rise in Q3 net profit

    February 9, 2024 7:40:00 PM

    AHMEDABAD: Homegrown pharma major, Zydus Lifesciences Limited on Friday posted ... The company�s board approved buyback of 57.9 lakh shares worth Rs 600 crore at Rs 1,005 per share via tender ...

    Published by : MSN
  10. Zydus Lifesciences Ltd (ZYDUSLIFE) Share Price

    July 12, 2024 3:30:00 AM

    Zydus Lifesciences Ltd share price was up by 1.01% from the previous closing price of ?1,163.35. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...

    Published by : Business Today

Read Zydus Lifesciences Buyback current news. Find Zydus Lifesciences Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Zydus Lifesciences Limited Buyback grey market premium and Zydus Lifesciences Buyback expected listing price.